Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jushi HoldingsJUSH 51 FCF Margin % is 6.06% as of Mar. 2026. GuruFocus rates JUSH with a GF Score™ of 51/100 and a GF Value™ of $0.53 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 963 Drug Manufacturers companies, Jushi Holdings ranks worse than 56.18% on this metric.
The historical data trend for Jushi Holdings's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Jushi Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jushi Holdings FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jushi Holdings's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Jushi Holdings's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jushi Holdings (JUSH) has a FCF Margin % of 6.06% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Jushi Holdings and its competitors. According to the industry distribution chart, Jushi Holdings ranks #541 out of 963 companies in the Drug Manufacturers industry, placing it in the top 56.2%.
Is Jushi Holdings' FCF Margin % too high?
Jushi Holdings' current FCF Margin % is 6.06%. The Drug Manufacturers industry median FCF Margin % is 2.58. Jushi Holdings' value of 6.06% is 134.9% above this industry median. Based on the distribution chart, Jushi Holdings ranks #541 out of 963 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Jushi Holdings has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jushi Holdings' FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Jushi Holdings ranks #541 out of 963 companies for FCF Margin %. This places Jushi Holdings in the lower half of its industry. The industry median FCF Margin % is 2.58. Jushi Holdings' value of 6.06% is 134.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.58, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jushi Holdings's current FCF Margin % of 6.06% is 134.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Jushi Holdings and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jushi Holdings's current FCF Margin % is 6.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jushi Holdings stock overvalued right now?
Based on GuruFocus' analysis, Jushi Holdings (JUSH) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.53, compared to a current price of $0.42 — trading 20.7% below its estimated fair value. The current FCF Margin % is 6.06% and 134.9% above the Drug Manufacturers industry median of 2.58. Jushi Holdings' overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Jushi Holdings (JUSH), the current FCF Margin % is 6.06% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jushi Holdings (JUSH) Overvalued in 2026?
Based on GuruFocus' analysis, Jushi Holdings stock appears to be undervalued.
The current stock price of $0.42 is trading 20.7% below its estimated GF Value™ of $0.53.
GuruFocus considers Jushi Holdings to be Modestly Undervalued.
Key valuation signals for JUSH:
FCF Margin %: 6.06%
GF Value™: $0.53 vs. price of $0.42 (20.7% below fair value)
Industry Position: 134.9% above the Drug Manufacturers median (#541 of 963)
No single metric tells the full story. See the JUSH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jushi Holdings Inc is a vertically integrated multi-state cannabis and hemp operator engaged in retail, distribution, cultivation, and processing in both medical and adult-use markets. The company operates a diverse portfolio of branded cannabis and hemp-derived assets built upon opportunistic acquisitions, distressed deals, and competitive applications. Its products are offered through brands like Hijinks, The Bank, The Lab, Seche, and Tasteology, among others. The company distributes its products through various retail dispensaries, including Nature's Remedy, Beyond Hello, and NuLeaf, and also operates an e-commerce platform called The Jushi Shop, offering branded apparel, accessories, and other products of its different brands. All of its revenues are generated within the United States.
51GF Score
Get the complete analysis for JUSH
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JUSH has been successfully added to your 
